Morgan Ventures Q3 FY26: Steep Losses Trigger Alarm as Interest Costs Surge

Feb 12 2026 08:19 PM IST
share
Share Via
Morgan Ventures Ltd., a micro-cap non-banking financial company with a market capitalisation of ₹68.00 crores, reported a sharp reversal to losses in Q3 FY26, posting a net loss of ₹5.13 crores compared to a profit of ₹5.91 crores in the previous quarter. The 187% quarter-on-quarter decline was driven by a dramatic 90.76% collapse in net sales to just ₹1.29 crores and ballooning interest expenses, raising serious concerns about the company's financial trajectory.
Morgan Ventures Q3 FY26: Steep Losses Trigger Alarm as Interest Costs Surge
Net Profit (Q3 FY26)
-₹5.13 Cr
▼ 187% QoQ
Net Sales (Q3 FY26)
₹1.29 Cr
▼ 90.76% QoQ
Interest Expense
₹4.23 Cr
▼ 16.73% QoQ
ROE (Average)
19.24%
5-Year Average

The stock closed at ₹69.99 on February 12, 2026, gaining 2.07% in the latest trading session but remaining 44.85% below its 52-week high of ₹126.90. The micro-cap NBFC, which focuses on financial and investment services, has seen its shares decline 12.93% over the past year, significantly underperforming the Sensex's 9.85% gain and the NBFC sector's 27.43% return. With a proprietary Mojo score of just 12 out of 100 and a "Strong Sell" rating, investor sentiment remains deeply cautious about the company's near-term prospects.

Financial Performance: A Quarter of Severe Deterioration

Morgan Ventures' Q3 FY26 results revealed a business under significant stress. Net sales plummeted to ₹1.29 crores from ₹13.96 crores in Q2 FY26, marking a catastrophic 90.76% quarter-on-quarter decline. On a year-on-year basis, sales fell 91.08% from ₹14.46 crores in Q3 FY25, indicating both sequential and annual deterioration. The collapse in revenue generation raises fundamental questions about the company's operational capacity and business model sustainability.

Quarter Net Sales (₹ Cr) QoQ Change Net Profit (₹ Cr) QoQ Change PAT Margin
Dec'25 (Q3) 1.29 -90.76% -5.13 -186.80% -397.67%
Sep'25 (Q2) 13.96 +152.44% 5.91 +462.86% 42.34%
Jun'25 (Q1) 5.53 -55.48% 1.05 -84.33% 18.99%
Mar'25 (Q4) 12.42 -14.11% 6.70 -27.80% 53.95%
Dec'24 (Q3) 14.46 +15.22% 9.28 +68.73% 64.18%
Sep'24 (Q2) 12.55 +113.07% 5.50 +9.78% 43.82%
Jun'24 (Q1) 5.89 5.01 85.06%

The operating profit before depreciation, interest, and tax (PBDIT) excluding other income turned deeply negative at -₹1.60 crores in Q3 FY26, compared to a robust ₹13.88 crores in Q2 FY26. This resulted in an operating margin of -124.03%, a stark contrast to the 99.43% margin achieved in the previous quarter. The profit before tax (PBT) stood at -₹5.83 crores, the lowest in the company's recent history, reflecting severe operational challenges.

Interest expenses remained elevated at ₹4.23 crores in Q3 FY26, though down 16.73% from ₹5.08 crores in Q2 FY26. However, with negligible revenue generation, these finance costs consumed the entire operational capacity of the business, pushing the company into deep losses. The PAT margin collapsed to -397.67%, indicating that for every rupee of sales, the company lost nearly four rupees—a financially unsustainable position.

Net Sales (Q3 FY26)
₹1.29 Cr
▼ 90.76% QoQ | ▼ 91.08% YoY
Net Profit (Q3 FY26)
-₹5.13 Cr
▼ 186.80% QoQ | ▼ 155.28% YoY
Operating Margin
-124.03%
vs 99.43% in Q2 FY26
PAT Margin
-397.67%
vs 42.34% in Q2 FY26

Operational Distress: Leverage and Revenue Crisis

Morgan Ventures operates with a high average net debt-to-equity ratio of 1.85, indicating significant leverage in its capital structure. While the company's average return on equity (ROE) of 19.24% over five years demonstrates historical capital efficiency, the latest quarter's performance suggests this profitability is no longer sustainable under current operational conditions. The ROE for the latest period stands at 23.83%, though this metric is distorted by the sharp quarterly loss and should be viewed with caution.

Critical Concern: Revenue Generation Collapse

The 90.76% quarter-on-quarter decline in net sales to just ₹1.29 crores represents the most severe revenue contraction in the company's recent history. This collapse, combined with sustained high interest expenses of ₹4.23 crores, has created a financially untenable situation. The company's ability to service debt obligations while generating minimal revenue raises urgent questions about business viability and management strategy.

The company's balance sheet as of March 2016 (the latest available annual data) showed shareholder funds of ₹38.82 crores with investments of ₹8.90 crores and fixed assets of ₹6.15 crores. Current liabilities stood at ₹9.48 crores with no long-term debt reported at that time. However, the recent surge in quarterly interest expenses suggests the company has taken on significant borrowings in subsequent periods, which are now weighing heavily on profitability amid collapsing revenues.

The return on capital employed (ROCE) for the latest period stands at 15.98%, calculated using earnings before interest and tax minus other income, divided by capital employed less cash and current investments. While this suggests reasonable capital productivity historically, the Q3 FY26 operational loss indicates that current returns have turned sharply negative, eroding the value created in prior periods.

NBFC Sector Context: Swimming Against the Tide

The broader NBFC sector has delivered a robust 27.43% return over the past year, driven by strong credit growth, improving asset quality, and favourable economic conditions. Morgan Ventures' 12.93% decline over the same period represents a stark 40.36% underperformance versus its sector peers, highlighting company-specific challenges rather than sectoral headwinds.

The micro-cap NBFC operates in a competitive landscape where scale, asset quality, and diversified revenue streams are critical success factors. With net sales of just ₹1.29 crores in Q3 FY26, Morgan Ventures appears to lack the operational scale necessary to compete effectively. The company's business model, which focuses on investments in equity instruments, units of alternative investment funds (AIF Category II and III), and onshore funds, requires substantial capital deployment and market expertise to generate consistent returns.

Sector Underperformance

Morgan Ventures' 1-year stock return of -12.93% trails the NBFC sector's +27.43% performance by a substantial 40.36 percentage points. This underperformance reflects investor concerns about the company's erratic quarterly performance, high leverage, and inability to generate stable revenues. With zero institutional holdings and a micro-cap status, the stock lacks the liquidity and institutional support that larger NBFCs enjoy.

Peer Comparison: Valuation Disconnect

Morgan Ventures trades at a price-to-earnings (P/E) ratio of 3.02x based on trailing twelve-month earnings, significantly below the industry average P/E of 23x. The company's price-to-book value (P/BV) ratio stands at 0.72x, indicating the stock trades at a 28% discount to its book value of ₹89.76 per share. While these metrics superficially suggest attractive valuation, the Q3 FY26 loss and deteriorating financial trend indicate that historical earnings may not be sustainable.

Company P/E (TTM) P/BV ROE (%) Debt/Equity
Morgan Ventures 3.02 0.72 19.24% 1.85
Ramchandra Leasing 591.86 6.15 0.0% 0.00
Gowra Leasing 12.81 1.92 9.47% 0.74
ISL Consulting NA (Loss Making) 5.25 6.04% 0.00
Apoorva Leasing NA (Loss Making) 0.47 0.0% 0.00

Compared to peers, Morgan Ventures demonstrates a higher average ROE of 19.24% versus the peer group average of approximately 4%, suggesting historically superior capital efficiency. However, the company also carries significantly higher leverage with a debt-to-equity ratio of 1.85, compared to peers like Gowra Leasing (0.74) and ISL Consulting (0.00). This leverage amplifies both returns and risks, and in the current environment of revenue collapse, it has become a critical vulnerability rather than a strategic advantage.

The low P/E multiple of 3.02x reflects market scepticism about earnings sustainability. With the company now loss-making in Q3 FY26, the trailing P/E ratio based on historical profits provides limited insight into fair value. The P/BV ratio of 0.72x suggests the market values the company's net assets at a significant discount, potentially reflecting concerns about asset quality or the ability to generate returns from deployed capital.

Valuation Analysis: Attractive Metrics Mask Fundamental Concerns

Morgan Ventures' current valuation metrics appear superficially attractive, with the stock trading at a P/E of 3.02x and P/BV of 0.72x, well below industry averages. The company's enterprise value-to-EBITDA (EV/EBITDA) ratio stands at 5.64x, and its EV-to-sales ratio is 5.33x. However, these multiples are calculated based on trailing performance that no longer reflects current operational reality.

The stock has been classified as "Attractive" in terms of valuation since July 2025, having oscillated between "Attractive," "Fair," and "Very Expensive" grades over the past year. This attractive valuation grade, however, is based on historical earnings power that has evaporated in Q3 FY26. With the company now loss-making and revenue generation severely impaired, traditional valuation metrics provide limited guidance for investment decisions.

P/E Ratio (TTM)
3.02x
vs Industry: 23x
Price to Book Value
0.72x
28% discount to book
EV/EBITDA
5.64x
Based on trailing data
Mojo Score
12/100
Strong Sell Zone

The stock currently trades at ₹69.99, down 44.85% from its 52-week high of ₹126.90 but up 8.03% from its 52-week low of ₹64.79. This positioning near the lower end of its annual range reflects sustained selling pressure and deteriorating investor confidence. The stock trades below all key moving averages—5-day (₹70.76), 20-day (₹69.42), 50-day (₹73.14), 100-day (₹74.36), and 200-day (₹86.14)—confirming a bearish technical trend that aligns with weakening fundamentals.

"With Q3 FY26 losses of ₹5.13 crores and revenue collapsing 90.76% quarter-on-quarter, Morgan Ventures faces an existential challenge in restoring operational viability and investor confidence."

Shareholding Pattern: Stable but Uninspiring

The shareholding pattern of Morgan Ventures has remained remarkably stable over the past five quarters, with promoter holdings steady at 74.80% and non-institutional investors holding the remaining 25.20%. There has been zero participation from foreign institutional investors (FIIs), mutual funds, insurance companies, or other domestic institutional investors (DIIs) across all reported quarters.

Category Dec'25 Sep'25 Jun'25 Mar'25 QoQ Change
Promoter 74.80% 74.80% 74.80% 74.80% 0.00%
FII 0.00% 0.00% 0.00% 0.00% 0.00%
Mutual Funds 0.00% 0.00% 0.00% 0.00% 0.00%
Insurance 0.00% 0.00% 0.00% 0.00% 0.00%
Other DII 0.00% 0.00% 0.00% 0.00% 0.00%
Non-Institutional 25.20% 25.20% 25.20% 25.20% 0.00%

The complete absence of institutional investors—zero FII holdings, zero mutual fund participation, and zero insurance company interest—is a significant red flag. Institutional investors typically conduct rigorous due diligence and bring professional governance oversight. Their complete avoidance of Morgan Ventures suggests concerns about the company's business model, financial transparency, or growth prospects. The high promoter holding of 74.80% provides control stability but limits free float and liquidity for minority investors.

Key promoter entities include Poysha Oxygen Private Limited (20.57%), Gas Supply Company Private Limited (15.05%), Goyal Udyog India Private Limited (14.90%), Poysha Fincorp Private Limited (10.10%), Yield Securities And Credits Private Limited (9.70%), and Virgin Securities And Credits Private Limited (4.48%). Notably, there is no promoter pledging reported, which is a positive factor indicating promoters are not leveraging their holdings for external borrowings.

Stock Performance: Multi-Year Gains Eroding

Morgan Ventures has delivered exceptional long-term returns despite recent struggles, with a 5-year return of 1,243.38% and a 10-year return of 474.63%, significantly outperforming the Sensex's 62.34% and 264.02% returns over the same periods. However, this stellar long-term performance has reversed sharply in recent periods, with the stock declining 12.93% over the past year while the Sensex gained 9.85%, resulting in a negative alpha of -22.78%.

Period Stock Return Sensex Return Alpha
1 Week -4.33% +0.43% -4.76%
1 Month -2.47% -0.24% -2.23%
3 Months -13.36% -0.94% -12.42%
6 Months -9.75% +4.29% -14.04%
YTD -6.83% -1.81% -5.02%
1 Year -12.93% +9.85% -22.78%
2 Years +63.34% +17.73% +45.61%
3 Years +31.31% +37.89% -6.58%
5 Years +1,243.38% +62.34% +1,181.04%

The stock's risk profile has deteriorated significantly, with an adjusted beta of 1.50, indicating 50% higher volatility than the broader market. Over the past year, the stock has generated a risk-adjusted return of -0.22 with volatility of 58.11%, compared to the Sensex's risk-adjusted return of 0.86 with volatility of just 11.44%. This places Morgan Ventures in the "High Risk Low Return" category, an unattractive combination for investors.

Technical indicators confirm the bearish sentiment, with the stock in a "Bearish" trend since February 6, 2026. The MACD indicator shows bearish signals on both weekly and monthly timeframes, while Bollinger Bands indicate mildly bearish conditions. The stock trades below all major moving averages, with immediate support at the 52-week low of ₹64.79 and resistance at the 20-day moving average of ₹69.42.

Investment Thesis: Warning Signals Across All Parameters

Morgan Ventures' investment thesis is severely challenged by deteriorating fundamentals across all key parameters. The company's Mojo score of 12 out of 100 places it firmly in "Strong Sell" territory, with the score declining from 20 in September 2025 and 36 in August 2025. This downward trajectory reflects worsening financial trends, technical weakness, and persistent operational challenges.

Valuation
Attractive
Low multiples vs peers
Quality Grade
Below Average
High leverage, weak trend
Financial Trend
Negative
Q3 losses, revenue collapse
Technical Trend
Bearish
Below all key MAs

The quality assessment rates Morgan Ventures as "Below Average," reflecting concerns about financial performance sustainability despite a respectable 5-year sales growth CAGR of 59.87% and EBIT growth of 64.56%. The high average net debt-to-equity ratio of 1.85 and complete absence of institutional holdings (0.0%) further weigh on the quality rating. The financial trend has turned "Negative" as of Q3 FY26, with the latest six-month sales declining 43.54% and quarterly PAT plummeting 155.30%.

Key Strengths & Risk Factors

✓ KEY STRENGTHS

  • Attractive Valuation: Trading at P/E of 3.02x and P/BV of 0.72x, significantly below industry averages
  • Strong Historical Returns: 5-year return of 1,243.38% demonstrates long-term wealth creation capability
  • Healthy Average ROE: 19.24% average ROE indicates historically efficient capital deployment
  • Stable Promoter Base: 74.80% promoter holding with zero pledging provides ownership stability
  • Long-Term Growth: 5-year sales CAGR of 59.87% and EBIT CAGR of 64.56% show historical expansion

⚠️ KEY CONCERNS

  • Catastrophic Revenue Decline: Q3 FY26 sales collapsed 90.76% QoQ to just ₹1.29 crores
  • Deep Quarterly Loss: Net loss of ₹5.13 crores in Q3 FY26 vs profit of ₹5.91 crores in Q2 FY26
  • High Interest Burden: Interest expense of ₹4.23 crores on minimal revenue creates unsustainable cost structure
  • Zero Institutional Confidence: No FII, mutual fund, or insurance participation indicates lack of professional investor interest
  • High Leverage: Net debt-to-equity of 1.85 amplifies downside risks in current environment
  • Bearish Technical Trend: Stock below all moving averages with high beta of 1.50
  • Sector Underperformance: 40.36% underperformance vs NBFC sector over past year

Outlook: Critical Monitoring Points Ahead

The immediate outlook for Morgan Ventures hinges on management's ability to stabilise revenue generation and restore operational profitability. The Q4 FY26 results, expected in the coming months, will be crucial in determining whether Q3's collapse was an aberration or the beginning of a sustained downturn. Investors should closely monitor revenue trends, interest cost management, and any strategic initiatives to improve asset deployment efficiency.

POSITIVE CATALYSTS

  • Revenue recovery to double-digit crore levels in Q4 FY26
  • Return to quarterly profitability with positive PAT
  • Reduction in interest expense burden through debt restructuring
  • Strategic asset reallocation to higher-yielding investments
  • Institutional investor participation or strategic partnership

RED FLAGS

  • Continued revenue decline below ₹5 crores in Q4 FY26
  • Sustained quarterly losses extending into FY27
  • Rising interest expenses or debt servicing challenges
  • Promoter stake reduction or pledging of shares
  • Further technical breakdown below ₹64.79 support
  • Regulatory concerns or compliance issues

The Verdict: Exit Recommended Amid Fundamental Deterioration

STRONG SELL

Score: 12/100

For Fresh Investors: Avoid initiating positions. The catastrophic 90.76% revenue decline in Q3 FY26, resulting in a ₹5.13 crore loss, signals severe operational distress. With zero institutional participation, high leverage, and a bearish technical trend, the risk-reward profile is highly unfavourable. Wait for sustained evidence of revenue stabilisation and return to profitability before considering entry.

For Existing Holders: Consider exiting positions to preserve capital. The company faces existential challenges with minimal revenue generation unable to service interest obligations. While historical long-term returns have been exceptional, current fundamentals suggest those gains are at risk of erosion. The stock's attractive valuation metrics are rendered meaningless by the absence of sustainable earnings power.

Rationale: Morgan Ventures' Q3 FY26 results reveal a business in crisis, with revenues collapsing to ₹1.29 crores and losses mounting to ₹5.13 crores. The combination of negative financial trends, bearish technicals, high leverage, and zero institutional confidence creates a toxic investment environment. Despite attractive valuation multiples and strong historical returns, the company's inability to generate meaningful revenue or control costs makes it a high-risk proposition with limited near-term recovery prospects.

Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)

⚠️ Investment Disclaimer

This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News